MEMC, Evonik settle trichlorosilane supply disputes

MEMC, Evonik settle trichlorosilane supply disputes

6:11 AM, 6th September 2012
MEMC, Evonik settle trichlorosilane supply disputes
Ahmad Chatila, President and CEO, MEMC.

ST PETERS, US: MEMC Electronic Materials Inc’s affiliate, MEMC Electronic Materials, SpA and Evonik Industries, have agreed to settle and resolve disputes related to two long-term take-or-pay supply agreements for the supply of trichlorosilane (TCS) to MEMC’s Merano, Italy polysilicon facility. MEMC will pay Evonik a total of €70 million in full settlement of all obligations. These payments will be made in installments over the next five quarters, including payment of €10 million in the current quarter.

Part of strategic restructuring strategy in December 2011, MEMC indicated it would idle the Merano facility and would consider closing the facility unless dramatic feedstock, power and other cost reductions were achieved. As a result of this decision, MEMC terminated the two long-term supply agreements with Evonik. In connection with the restructuring, MEMC recorded significant restructuring accruals in the 4th quarter of 2011.

As part of the settlement agreements, MEMC will acquire the Evonik TCS production plant, which is located on MEMC’s Merano site. At this time, a decision to restart the MEMC Merano facility has not been made, although settlement of the supply agreements is a significant step toward achieving these cost reduction goals. Both plants will continue to be idle pending resolution of a number of cost-related discussions with the Italian government and other parties.

“We are pleased that we were able to work collaboratively with an important supplier like Evonik to reach an amicable settlement. Our partners at Evonik recognized the seismic shift in solar that occurred in 2011 and worked with us to find a solution that benefitted both parties,” commented Ahmad Chatila, President and CEO, MEMC.

As a result of these settlement agreements, MEMC expects to recognize a material benefit to operating income in the 3rd quarter 2012 due to the favourable settlement of these agreements. The 3rd quarter installment payment is likely to reduce cash balance of €10 million.

© WOC News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Starpharma, AstraZeneca sign cancer drug agreement

MELBOURNE, AUSTRALIA: Starpharma Holdings Ltd signed an agreement with global pharmaceutical company AstraZeneca giving AstraZeneca the right to test ...

Read more
Orascom to invest $1.4 billion in fertilizer plant in Iowa, US

CAIRO, EGYPT: Egypt’s Orascom Construction Industries plans to invest $1.4 billion in a fertilizer plant in Iowa, US shunning overtures from nei ...

Read more
FMC, BCEER, BRISEA JV to market environmental technologies in China

PHILADELPHIA, US: FMC Corporation, BCEG Environmental Remediation Co Ltd (BCEER), and BRISEA Group Inc, have signed a definitive agreement to form a j ...

Read more
Clariant, Emerald Technology Ventures partner for cleantech sector

MUTTENZ, SWITZERLAND: Swiss specialty chemicals group, Clariant entered into a partnership agreement with Emerald Technology Ventures. Clariant will c ...

Read more
Scientists show way to improved water-splitting catalysts

CALIFORNIA, US: Scientists and engineers around the world are working to find a way to power the planet using solar-powered fuel cells. Such green sys ...

Read more
Bayer CropScience, Mendel to co-develop herbicide resistance breaking technology

MONHEIM, GERMANY: Bayer CropScience and Mendel Biotechnology Inc Hayward, California, USA have agreed for a new multi-year collaboration to jointly id ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X